Profile
PTPI ZTS TAK HLN TEVA ITCI
Company Name Petros Pharmaceuticals, Inc. Zoetis Inc. Takeda Pharmaceutical Company Limited Haleon plc Teva Pharmaceutical Industries Limited Intra-Cellular Therapies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $1.09M $73.16B $47.84B $46.09B $19.51B $14.05B
Employees 0.02K 13.80K 49.28K 24.56K 37.00K 0.86K
CEO Fady Boctor Ms. Kristin C. Peck Mr. Christophe Weber Brian James McNamara Richard D. Francis Dr. Sharon Mates Ph.D.
Ratings
PTPI ZTS TAK HLN TEVA ITCI
Quant Rating Score 2 3 3 3 2 1
Quant Rating Sell Neutral Neutral Neutral Sell Strong Sell
Trading
PTPI ZTS TAK HLN TEVA ITCI
Last Close $0.0349 $159.18 $15.34 $10.25 $17.01 $131.87
High 52 $0.5 $196.48 $15.46 $11.41 $22.77 $131.91
Low 52 $0.01 $144.45 $12.89 $8.47 $12.82 $69.56
Price vs. 52 Week High -93.02 % -18.98 % -0.78 % -10.17 % -25.3 % -0.03 %
Price vs. 52 Week Low 249 % 10.2 % 19.01 % 21.02 % 32.68 % 89.58 %
Total Return
PTPI ZTS TAK HLN TEVA ITCI
1 Month Return 9.4 % -5.63 % 2.33 % -7.7 % -1.39 % 0 %
3 Month Return -47.91 % 4.91 % 4.21 % 3.64 % 23.26 % 0 %
6 Month Return -91.18 % -2.53 % 15.69 % 8.35 % -19.92 % 57.51 %
9 Month Return -90.17 % -16.23 % 6.31 % -1.16 % -2.74 % 80.92 %
YTD Return -91.14 % -2.3 % 15.86 % 7.44 % -22.82 % 57.89 %
1 Year Return -91.59 % -9.02 % 16.12 % 21.02 % 3.72 % 89.58 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
PTPI ZTS TAK HLN TEVA ITCI
Dividend Yield Percentage (TTM) - 1.13 % 4.52 % 0.01 % - -
Dividend Paid and Capex Coverage Ration (TTM) -9.88 % 2 % 1.65 % - 2.53 % -227.26 %
Dividend Per Share (TTM) - 1.86 % 196 % 0.05 % - -
Payout Ratio (TTM) -1.91 % 32.25 % 280.28 % - - -
Profitability
PTPI ZTS TAK HLN TEVA ITCI
Gross Profit Margin TTM 76.34 % 70.2 % 54.7 % 61.52 % 49.17 % 91.63 %
Return on Assets TTM -81.88 % 17.86 % 0.76 % 4.2 % -3.35 % -5.46 %
Return on Equity TTM 1214.34 % 51.32 % 1.48 % 8.73 % -21.38 % -7.4 %
Return on Capital Employed TTM 159.66 % 32.08 % 3.75 % 7.74 % 1.59 % -10.05 %
Net Income Per EBT TTM 107.94 % 78.79 % 61.12 % 75.5 % 246.36 % 100.64 %
EBT Per Ebit TTM 87.81 % 92.99 % 40.08 % 86.58 % -120.28 % 63.57 %
EBIT Per Revenue TTM -408.52 % 37.01 % 9.62 % 19.64 % 2.61 % -17.15 %
Cash Flow To Debt Ratio TTM - 43.63 % 21.32 % - 7.47 % -430.93 %
Receivables Turnover TTM - 6.82 6.32 5.9 4.91 4.09
Payables Turnover TTM 1.16 6.51 4.36 2.19 3.69 2.18
Inventory Turnover TTM - 1.16 1.7 3.63 2.6 2.17
Fixed Asset Turnover TTM - 253.65 % 232.78 % 584.75 % 332.7 % 4569.25 %
Asset Turnover TTM 21.15 % 65.87 % 32.15 % 32.73 % 43.25 % 49.79 %
Operating Cash Flow Per Share TTM -2.55 6.58 608.55 - 1.11 -0.71
Free Cash Flow Per Share TTM -2.57 5.1 443.26 - 0.67 -0.71
Cash Per Share TTM 768.73 % 384.5 % 24349.44 % 24.05 % 149.12 % 970.67 %
Operating Cash Flow Sales Ratio TTM -79.58 % 31.71 % 21.01 % - 7.62 % -10.75 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.83 % 77.45 % 72.84 % - 60.43 % 100.44 %
Cash Flow Coverage Ratios TTM - 43.63 % 21.32 % - 7.47 % -430.93 %
Price To Free Cash Flows Ratio TTM -0.37 32.07 9.73 - 25.65 -191.12
Price To Operating Cash Flows Ratio TTM -0.01 24.98 7.13 - 15.38 -185.85
Price Cash Flow Ratio TTM -0.01 24.98 7.13 - 15.38 -185.85
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 4.54
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 1.37
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 9.19
ALVOW Alvotech 1.73
AMPH Amphastar Pharmaceuticals, Inc. 23.2
AMRX Amneal Pharmaceuticals, Inc. 8.42
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 65.28
APUS Apimeds Pharmaceuticals US, Inc 1.78
AQST Aquestive Therapeutics, Inc. 3.72
ASRT Assertio Holdings, Inc. 0.653
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 8.93
ETFs With Exposure to PTPI
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0 197.5
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 149.82
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 149.83
VEMPX Vanguard Extended Market Index InstlPlus 0 369.73
Unlock